Medicare

Amid rising cases of botched hair transplant procedures, India is bringing in regulations for the growing industry. The stiff standards aim to tighten oversight on who can perform such procedures, the infrastructure and safety requirements the clinics must meet.

The U.S. has reached a new borrowing milestone in its struggle to get hold of its finances.

China's enforcement of mandatory inspections for foreign generic drug makers could impose new challenges for India's pharmaceutical industry.

State drug regulators have been told to monitor distribution networks and crack down on suspect semaglutide batches after an Interpol alert linked to a counterfeit product detected in Austria.

While others made money producing generics by copying foreign discoveries, they bet on drug discovery in India, selling the family silver to fund their dreams. Now, after decades, they are seeing a payoff or within kissing distance of one.

As part of the plan, the government aims to boost product margins gradually to up to 50% for retailers operating these pharmacies, set up under the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) to sell affordable, high-quality generic drugs.

India is introducing a standardized fee structure for medical device testing to replace inconsistent market rates and enhance manufacturing traceability.

With CDSCO restricting vaccine and biologic testing to government labs, experts weigh the benefits of rigorous control against potential delays for a sector crucial to global healthcare supply.